FMP

FMP

Enter

ELAN - Elanco Animal Health...

Financial Summary of Elanco Animal Health Incorporated(ELAN), Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and

photo-url-https://financialmodelingprep.com/image-stock/ELAN.png

Elanco Animal Health Incorporated

ELAN

NYSE

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

13.46 USD

0.53 (3.94%)

About

ceo

Mr. Jeffrey N. Simmons

sector

Healthcare

industry

Drug Manufacturers - Specialty & Generic

website

https://www.elanco.com

exchange

NYSE

Description

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebi...

CIK

0001739104

ISIN

US28414H1032

CUSIP

28414H103

Address

2500 Innovation Way

Phone

877 352 6261

Country

US

Employee

9,300

IPO Date

Sep 20, 2018

Summary

CIK

0001739104

Exchange

NYSE

Industry

Drug Manufacturers -...

Sector

Healthcare

CUSIP

28414H103

ISIN

US28414H1032

Country

US

Price

13.46

Beta

1.3

Volume Avg.

4.16M

Market Cap

6.64B

Shares

-

52-Week

7.88-16.88

DCF

-8.11

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-5.38

P/B

-

Website

https://www.elanco.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest ELAN News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep